Sandra Sharpe

467 total citations
10 papers, 411 citations indexed

About

Sandra Sharpe is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Sandra Sharpe has authored 10 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Sandra Sharpe's work include HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (4 papers) and HIV/AIDS drug development and treatment (3 papers). Sandra Sharpe is often cited by papers focused on HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (4 papers) and HIV/AIDS drug development and treatment (3 papers). Sandra Sharpe collaborates with scholars based in United States and France. Sandra Sharpe's co-authors include Susan Zolla‐Pazner, Miroslaw K. Górny, Gene M. Shearer, David I. Cohen, Lígia A. Pinto, Gregory T. Spear, Daniel M. Takefman, Mahmood Ghassemi, Hiroshi Mizuma and Michael Marmor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Virology.

In The Last Decade

Sandra Sharpe

10 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Sharpe United States 8 343 226 119 94 82 10 411
Kathleen Hillman United States 10 222 0.6× 194 0.9× 74 0.6× 80 0.9× 67 0.8× 13 353
Gary Clements United Kingdom 3 321 0.9× 141 0.6× 171 1.4× 77 0.8× 58 0.7× 3 366
Ellis L. Reinherz United States 4 191 0.6× 283 1.3× 72 0.6× 107 1.1× 63 0.8× 6 429
C. De Santis Italy 11 292 0.9× 333 1.5× 93 0.8× 48 0.5× 69 0.8× 20 465
Rachel M. Klein United States 4 492 1.4× 370 1.6× 163 1.4× 104 1.1× 73 0.9× 5 558
Thomas Decoville France 12 354 1.0× 350 1.5× 86 0.7× 111 1.2× 99 1.2× 21 507
Frederick H. Jaeger United States 11 259 0.8× 185 0.8× 98 0.8× 106 1.1× 79 1.0× 12 423
Nicole L. Yates United States 12 437 1.3× 365 1.6× 155 1.3× 146 1.6× 89 1.1× 24 588
Leia Wren Australia 9 304 0.9× 331 1.5× 75 0.6× 108 1.1× 59 0.7× 10 412
Iliyana Mikell United States 8 351 1.0× 284 1.3× 122 1.0× 94 1.0× 136 1.7× 9 473

Countries citing papers authored by Sandra Sharpe

Since Specialization
Citations

This map shows the geographic impact of Sandra Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sharpe more than expected).

Fields of papers citing papers by Sandra Sharpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sharpe. The network helps show where Sandra Sharpe may publish in the future.

Co-authorship network of co-authors of Sandra Sharpe

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Sharpe. A scholar is included among the top collaborators of Sandra Sharpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Sharpe. Sandra Sharpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pinto, Lígia A., Sandra Sharpe, David I. Cohen, & Gene M. Shearer. (1998). Alloantigen-Stimulated Anti-HIV Activity. Blood. 92(9). 3346–3354. 12 indexed citations
2.
Pinto, Lígia A., Sandra Sharpe, David I. Cohen, & Gene M. Shearer. (1998). Alloantigen-Stimulated Anti-HIV Activity. Blood. 92(9). 3346–3354. 38 indexed citations
3.
Zolla‐Pazner, Susan, Carl R. Alving, Robert B. Belshe, et al.. (1997). Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus—Uninfected Recipients of Candidate AIDS Vaccines. The Journal of Infectious Diseases. 175(4). 764–774. 39 indexed citations
4.
Zolla‐Pazner, Susan & Sandra Sharpe. (1995). A Resting Cell Assay for Improved Detection of Antibody-Mediated Neutralization of HIV Type 1 Primary Isolates. AIDS Research and Human Retroviruses. 11(12). 1449–1458. 49 indexed citations
5.
Spear, Gregory T., Daniel M. Takefman, Sandra Sharpe, Mahmood Ghassemi, & Susan Zolla‐Pazner. (1994). Antibodies to the HIV-1 V3 Loop in Serum from Infected Persons Contribute a Major Proportion of Immune Effector Functions Including Complement Activation, Antibody Binding, and Neutralization. Virology. 204(2). 609–615. 40 indexed citations
6.
Donoghue, Eileen T., Sandra Sharpe, E Boone, et al.. (1994). Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein. Journal of Virology. 68(3). 1942–1950. 1 indexed citations
7.
Laal, Suman, Sherri Burda, Sandra Sharpe, & Susan Zolla‐Pazner. (1993). A Rapid, Automated Microtiter Assay for Measuring Neutralization of HIV-1. AIDS Research and Human Retroviruses. 9(8). 781–785. 14 indexed citations
8.
Stickler, Marcia, Sandra Sharpe, & Susan Zolla‐Pazner. (1992). p24 Antibody Production in p24 Antibody-Negative HIV-Infected Subjects. Viral Immunology. 5(2). 123–132. 1 indexed citations
9.
Górny, Miroslaw K., et al.. (1989). Generation of human monoclonal antibodies to human immunodeficiency virus.. Proceedings of the National Academy of Sciences. 86(5). 1624–1628. 167 indexed citations
10.
Mizuma, Hiroshi, Susan Zolla‐Pazner, Stephen D. Litwin, et al.. (1987). Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.. PubMed. 68(1). 5–14. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026